218 related articles for article (PubMed ID: 25404736)
41. AMP-activated protein kinase mediates lipopolysaccharide-induced proinflammatory responses and elevated bone resorption in differentiated osteoclasts.
Chen YH; Hsueh KK; Chu PW; Chen SK
J Cell Biochem; 2022 Feb; 123(2):275-288. PubMed ID: 34668232
[TBL] [Abstract][Full Text] [Related]
42. Osthole Inhibits M1 Macrophage Polarization and Attenuates Osteolysis in a Mouse Skull Model.
Wang F; Yang P; Wan T; Liu C; Zhu Y; Chen X; Liu H
Oxid Med Cell Longev; 2023; 2023():2975193. PubMed ID: 36686380
[TBL] [Abstract][Full Text] [Related]
43. Foreign body-type multinucleated giant cell formation is potently induced by alpha-tocopherol and prevented by the diacylglycerol kinase inhibitor R59022.
McNally AK; Anderson JM
Am J Pathol; 2003 Sep; 163(3):1147-56. PubMed ID: 12937156
[TBL] [Abstract][Full Text] [Related]
44. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
[TBL] [Abstract][Full Text] [Related]
45. In vivo quantitative and qualitative assessment of foreign body giant cell formation on biomaterials in mice deficient in natural killer lymphocyte subsets, mast cells, or the interleukin-4 receptorα and in severe combined immunodeficient mice.
Yang J; Jao B; McNally AK; Anderson JM
J Biomed Mater Res A; 2014 Jun; 102(6):2017-23. PubMed ID: 24616384
[TBL] [Abstract][Full Text] [Related]
46. Nanoparticle delivery of miR-223 to attenuate macrophage fusion.
Moore LB; Sawyer AJ; Saucier-Sawyer J; Saltzman WM; Kyriakides TR
Biomaterials; 2016 May; 89():127-35. PubMed ID: 26967647
[TBL] [Abstract][Full Text] [Related]
47. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
[TBL] [Abstract][Full Text] [Related]
48. Regulators of osteoclast differentiation and cell-cell fusion.
Miyamoto T
Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633
[TBL] [Abstract][Full Text] [Related]
49. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.
Wu Z; Wu H; Li C; Fu F; Ding J; Shao S; Li K; Yu X; Su Y; Liang J; Lin X; Yuan G; Zhou J; Song F; Zhao J; Xu J; Liu Q; Xu F
J Cell Physiol; 2019 Aug; 234(10):17812-17823. PubMed ID: 30815894
[TBL] [Abstract][Full Text] [Related]
50. Multinucleated giant cells in the implant bed of bone substitutes are foreign body giant cells-New insights into the material-mediated healing process.
Barbeck M; Booms P; Unger R; Hoffmann V; Sader R; Kirkpatrick CJ; Ghanaati S
J Biomed Mater Res A; 2017 Apr; 105(4):1105-1111. PubMed ID: 28093892
[TBL] [Abstract][Full Text] [Related]
51. Silencing of Ac45 Simultaneously Inhibits Osteoclast-Mediated Bone Resorption and Attenuates Dendritic Cell-Mediated Inflammation through Impairing Acidification and Cathepsin K Secretion.
Yang W; Zhu Z; Li L; McVicar A; Gao N; Wang L; Li YP; Chen W
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077625
[TBL] [Abstract][Full Text] [Related]
52. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.
Inoue K; Hu X; Zhao B
FASEB J; 2020 Feb; 34(2):2392-2407. PubMed ID: 31908034
[TBL] [Abstract][Full Text] [Related]
53. Cannabinoid Receptor 2 Agonist Prevents Local and Systemic Inflammatory Bone Destruction in Rheumatoid Arthritis.
Zhu M; Yu B; Bai J; Wang X; Guo X; Liu Y; Lin J; Hu S; Zhang W; Tao Y; Hu C; Yang H; Xu Y; Geng D
J Bone Miner Res; 2019 Apr; 34(4):739-751. PubMed ID: 30508319
[TBL] [Abstract][Full Text] [Related]
54. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
[TBL] [Abstract][Full Text] [Related]
55. IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.
Xiong Y; Pennini M; Vogel SN; Medvedev AE
J Leukoc Biol; 2013 Aug; 94(2):291-300. PubMed ID: 23695305
[TBL] [Abstract][Full Text] [Related]
56. An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion.
Miyamoto H; Katsuyama E; Miyauchi Y; Hoshi H; Miyamoto K; Sato Y; Kobayashi T; Iwasaki R; Yoshida S; Mori T; Kanagawa H; Fujie A; Hao W; Morioka H; Matsumoto M; Toyama Y; Miyamoto T
J Biol Chem; 2012 Sep; 287(39):32479-84. PubMed ID: 22865856
[TBL] [Abstract][Full Text] [Related]
57. Paeoniflorin Inhibits Receptor Activator for Nuclear Factor κB (RANK) Ligand-Induced Osteoclast Differentiation In Vitro and Particle-Induced Osteolysis In Vivo.
Li Z; Li D; Chen X
Med Sci Monit; 2018 Feb; 24():1044-1053. PubMed ID: 29459582
[TBL] [Abstract][Full Text] [Related]
58. LY411575, a potent γ-secretase inhibitor, suppresses osteoclastogenesis in vitro and LPS-induced calvarial osteolysis in vivo.
Chen X; Chen X; Zhou Z; Qin A; Wang Y; Fan B; Xu W; Zhang S
J Cell Physiol; 2019 Nov; 234(11):20944-20956. PubMed ID: 31020651
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway.
Yang H; Xu Y; Zhu M; Gu Y; Zhang W; Shao H; Wang Y; Ping Z; Hu X; Wang L; Geng D
Biomaterials; 2016 Feb; 80():1-10. PubMed ID: 26695376
[TBL] [Abstract][Full Text] [Related]
60. Role for interleukin-4 in foreign-body giant cell formation on a poly(etherurethane urea) in vivo.
Kao WJ; McNally AK; Hiltner A; Anderson JM
J Biomed Mater Res; 1995 Oct; 29(10):1267-75. PubMed ID: 8557729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
